EE05172B1 - Mesoprogestiinid (progesterooniretseptori modulaatorid) healoomuliste hormoons?ltuvate gnekoloogiliste haiguste raviks ja vltimiseks - Google Patents
Mesoprogestiinid (progesterooniretseptori modulaatorid) healoomuliste hormoons?ltuvate gnekoloogiliste haiguste raviks ja vltimiseksInfo
- Publication number
- EE05172B1 EE05172B1 EEP200200104A EEP200200104A EE05172B1 EE 05172 B1 EE05172 B1 EE 05172B1 EE P200200104 A EEP200200104 A EE P200200104A EE P200200104 A EEP200200104 A EE P200200104A EE 05172 B1 EE05172 B1 EE 05172B1
- Authority
- EE
- Estonia
- Prior art keywords
- mesoprogestins
- prevention
- treatment
- receptor modulators
- progesterone receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38614199A | 1999-08-31 | 1999-08-31 | |
PCT/US2000/023770 WO2001015679A2 (en) | 1999-08-31 | 2000-08-31 | Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200200104A EE200200104A (et) | 2003-04-15 |
EE05172B1 true EE05172B1 (et) | 2009-06-15 |
Family
ID=23524338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200200104A EE05172B1 (et) | 1999-08-31 | 2000-08-31 | Mesoprogestiinid (progesterooniretseptori modulaatorid) healoomuliste hormoons?ltuvate gnekoloogiliste haiguste raviks ja vltimiseks |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP1229906B1 (sl) |
JP (1) | JP2003535029A (sl) |
KR (3) | KR100755109B1 (sl) |
AR (1) | AR025457A1 (sl) |
AT (1) | ATE375160T1 (sl) |
AU (1) | AU781840B2 (sl) |
BG (1) | BG65817B1 (sl) |
BR (1) | BR0014161A (sl) |
CA (1) | CA2382580C (sl) |
CO (1) | CO5200772A1 (sl) |
CZ (1) | CZ2002704A3 (sl) |
DE (1) | DE60036723T2 (sl) |
DK (1) | DK1229906T3 (sl) |
EA (1) | EA007854B1 (sl) |
EE (1) | EE05172B1 (sl) |
ES (1) | ES2295050T3 (sl) |
HR (1) | HRP20020267A2 (sl) |
HU (1) | HUP0202429A3 (sl) |
IL (1) | IL148416A0 (sl) |
LT (1) | LT5034B (sl) |
LV (1) | LV12941B (sl) |
ME (1) | MEP13808A (sl) |
MX (1) | MXPA02002191A (sl) |
NO (1) | NO20020999L (sl) |
NZ (1) | NZ517471A (sl) |
PE (1) | PE20010578A1 (sl) |
PL (1) | PL198790B1 (sl) |
PT (1) | PT1229906E (sl) |
RO (1) | RO122179B1 (sl) |
RS (1) | RS50283B (sl) |
SI (1) | SI20852B (sl) |
SK (1) | SK287192B6 (sl) |
UA (1) | UA78184C2 (sl) |
WO (1) | WO2001015679A2 (sl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
DE50304970D1 (de) * | 2002-08-02 | 2006-10-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie |
US20040097591A1 (en) * | 2002-11-18 | 2004-05-20 | Kristof Chwalisz | Use of selective progesterone receptor modulators for the treatment of androgen deficiency |
DE102007011105A1 (de) | 2007-03-02 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose |
WO2010147184A1 (ja) * | 2009-06-17 | 2010-12-23 | 国立大学法人熊本大学 | 月経困難症の予防及び/又は治療薬 |
US8399432B2 (en) * | 2009-10-27 | 2013-03-19 | Lipogen Ltd. | Compositions and methods of treatment for alleviating premenstrual syndrome symptoms |
JP2022548314A (ja) * | 2019-09-23 | 2022-11-17 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3633244A1 (de) | 1986-09-26 | 1988-03-31 | Schering Ag | Antigestagene zur hemmung der uterinen prostaglandinsynthese |
DE4332284C2 (de) | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US5681817A (en) * | 1994-02-04 | 1997-10-28 | The Medical College Of Hampton Roads | Treatment of ovarian estrogen dependent conditions |
US5576310A (en) * | 1994-09-20 | 1996-11-19 | Jenapharm Gmbh | 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds |
US5688810A (en) * | 1994-12-22 | 1997-11-18 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
EP1382597A3 (en) * | 1994-12-22 | 2004-04-07 | Ligand Pharmaceuticals, Inc. | Steroid receptor modulator compounds and methods |
ES2196063T3 (es) | 1995-02-02 | 2003-12-16 | Schering Ag | Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales. |
DE19604231A1 (de) * | 1996-01-29 | 1997-07-31 | Schering Ag | Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen |
AU710139B2 (en) * | 1996-05-01 | 1999-09-16 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | 21-substituted progesterone derivatives as new antiprogestational agents |
WO1998005679A2 (en) * | 1996-08-05 | 1998-02-12 | Duke University | Mixed agonists of the progesterone receptor and assays therefor |
DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
HUP0105134A2 (hu) * | 1999-01-14 | 2002-04-29 | Bayer Corporation | Szubsztituált 2-arilimino-heterociklusok és ilyen vegyületeket tartalmazó készítmények progeszteron receptorhoz kötődő szerekként való alkalmazásra |
WO2000066590A2 (en) * | 1999-05-04 | 2000-11-09 | Ligand Pharmaceuticals, Inc. | Tetracyclic progesterone receptor modulator compounds and methods |
-
2000
- 2000-08-31 RO ROA200200229A patent/RO122179B1/ro unknown
- 2000-08-31 NZ NZ517471A patent/NZ517471A/en unknown
- 2000-08-31 KR KR1020027002790A patent/KR100755109B1/ko not_active IP Right Cessation
- 2000-08-31 BR BR0014161-5A patent/BR0014161A/pt not_active Application Discontinuation
- 2000-08-31 JP JP2001519893A patent/JP2003535029A/ja active Pending
- 2000-08-31 EE EEP200200104A patent/EE05172B1/xx not_active IP Right Cessation
- 2000-08-31 PE PE2000000893A patent/PE20010578A1/es not_active Application Discontinuation
- 2000-08-31 AU AU69466/00A patent/AU781840B2/en not_active Ceased
- 2000-08-31 PT PT00957914T patent/PT1229906E/pt unknown
- 2000-08-31 DE DE60036723T patent/DE60036723T2/de not_active Expired - Lifetime
- 2000-08-31 CZ CZ2002704A patent/CZ2002704A3/cs unknown
- 2000-08-31 CO CO00065515A patent/CO5200772A1/es not_active Application Discontinuation
- 2000-08-31 ES ES00957914T patent/ES2295050T3/es not_active Expired - Lifetime
- 2000-08-31 SK SK299-2002A patent/SK287192B6/sk unknown
- 2000-08-31 EA EA200200282A patent/EA007854B1/ru not_active IP Right Cessation
- 2000-08-31 DK DK00957914T patent/DK1229906T3/da active
- 2000-08-31 CA CA002382580A patent/CA2382580C/en not_active Expired - Lifetime
- 2000-08-31 KR KR1020087016247A patent/KR20080066095A/ko not_active Application Discontinuation
- 2000-08-31 RS YUP-140/02A patent/RS50283B/sr unknown
- 2000-08-31 HU HU0202429A patent/HUP0202429A3/hu unknown
- 2000-08-31 PL PL353930A patent/PL198790B1/pl not_active IP Right Cessation
- 2000-08-31 EP EP00957914A patent/EP1229906B1/en not_active Expired - Lifetime
- 2000-08-31 UA UA2002032430A patent/UA78184C2/uk unknown
- 2000-08-31 WO PCT/US2000/023770 patent/WO2001015679A2/en active IP Right Grant
- 2000-08-31 AR ARP000104538A patent/AR025457A1/es unknown
- 2000-08-31 KR KR1020077011455A patent/KR100864547B1/ko not_active IP Right Cessation
- 2000-08-31 SI SI200020042A patent/SI20852B/sl not_active IP Right Cessation
- 2000-08-31 AT AT00957914T patent/ATE375160T1/de not_active IP Right Cessation
- 2000-08-31 IL IL14841600A patent/IL148416A0/xx unknown
- 2000-08-31 ME MEP-138/08A patent/MEP13808A/xx unknown
-
2002
- 2002-02-26 BG BG106442A patent/BG65817B1/bg unknown
- 2002-02-28 NO NO20020999A patent/NO20020999L/no not_active Application Discontinuation
- 2002-02-28 MX MXPA02002191A patent/MXPA02002191A/es active IP Right Grant
- 2002-03-21 LT LT2002031A patent/LT5034B/lt not_active IP Right Cessation
- 2002-03-28 HR HR20020267A patent/HRP20020267A2/xx not_active Application Discontinuation
- 2002-03-28 LV LVP-02-53A patent/LV12941B/lv unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69807634D1 (de) | Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen | |
NO20020912D0 (no) | Bicykliske androgen- og progesteronreseptorer- modulatorforbindelser og fremgangsmåter | |
NO20024478D0 (no) | Hormonerstatningsterapi ved anvendelse av kombinasjon av konjugerte östrogener og medroksyprogesteronacetat | |
IS4385A (is) | Stjórnuð losun stera úr sykruhúðum | |
CY2009015I1 (el) | Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο | |
DK0956858T3 (da) | Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner | |
NO20014379L (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
DK2455083T3 (da) | Farmaceutisk sammensætning til dermal anvendelse omfattende calcipotriol og betamethason til behandling af psoriasis | |
NO20004935D0 (no) | Anordning til den transdermale avleveringen av diklofenak | |
AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
NO20022087L (no) | Fremgangsmåte for behandling av diabetes | |
NO20005885L (no) | Kombinasjonsterapi for behandling av refraktær depresjon | |
ATE295174T1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
NO20010468L (no) | Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi | |
AU1262501A (en) | Compositions for transdermal and transmucosal administration of therapeutic agents | |
NO20003229L (no) | Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer | |
DE69620691D1 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
EE05172B1 (et) | Mesoprogestiinid (progesterooniretseptori modulaatorid) healoomuliste hormoons?ltuvate gnekoloogiliste haiguste raviks ja vltimiseks | |
NO20014049L (no) | Kontrollert frigjörings-formulering for behandling av COPD | |
EE200000333A (et) | Eesnäärmevähi ravis kasutatav konjugaat ning farmatseutiline kompositsioon ja selle valmistamismeetod | |
HUP0600234A3 (en) | Gel composition containing at least one steroid and trans-scrotal application of the composition for the treatment of hypogonadism | |
EE200200103A (et) | Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina | |
HUP0202741A3 (en) | Pharmaceutical composition available for the therapeutic management of endometriosis and fallopian tube obstruction and process for its preparation | |
DE60032655D1 (de) | Einrichtung zur Chirurgie der Hornhaut | |
NO20023841D0 (no) | Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemethos menn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HD1A | Correction of address | ||
GB1A | Change in the ownership or in the address of the owner | ||
HB1A | Correction of owner name or address | ||
HH1A | Change of representative | ||
HC1A | Change of owner name | ||
HE1A | Change of address | ||
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20100831 |